Comparing Dual Mini-fragment Plating to Single Precontoured Plating of Acute Midshaft Clavicle Fractures Trial
Launched by SUNNYBROOK HEALTH SCIENCES CENTRE · Jan 28, 2022
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical methods for fixing broken collarbones, specifically in the middle part of the bone, known as the midshaft. One method uses a single pre-shaped plate, while the other method uses two smaller plates. The goal of the study is to see if using the two smaller plates leads to fewer patients needing to have their plates removed later, while still ensuring the bone heals properly and there are no more complications.
To participate in this trial, individuals must be between 18 and 65 years old and have a completely displaced midshaft clavicle fracture, meaning the broken pieces of the bone do not touch at all. Participants will undergo surgery with one of the two methods and will be monitored during their recovery. This study is important because many patients experience discomfort from the plates used in surgery, and finding a more effective method could help reduce the need for additional procedures in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between 18 and 65 years of age
- • A completely displaced midshaft fracture of the clavicle (no cortical contact between the main proximal and distal fragments (AO/OTA 15.2A/B/C)
- • Fracture amenable to plate fixation with a minimum of three screws in each proximal and distal fragment
- Exclusion Criteria:
- • Open fracture
- • Pathological fracture
- • Fracture seen \> 28 days after injury
- • Associated neurovascular injury
- • Associated head injury (Glasgow Coma Scale \< 12)
- • Concomitant ipsilateral upper extremity fracture
- • Significant medical comorbidities (i.e., ASA grade IV and V)
- • Inability to comply with follow-up and
- • Lack of consent
About Sunnybrook Health Sciences Centre
Sunnybrook Health Sciences Centre is a leading academic health science organization located in Toronto, Canada, renowned for its commitment to advancing patient care through innovative research and education. As a prominent clinical trial sponsor, Sunnybrook integrates cutting-edge medical research with clinical practice, focusing on a wide range of health disciplines, including cancer care, trauma, and cardiovascular health. The center collaborates with various stakeholders, including academic institutions, healthcare providers, and industry partners, to facilitate the development of novel therapies and improve health outcomes. With a robust infrastructure and a dedicated team of researchers and clinicians, Sunnybrook plays a pivotal role in translating scientific advancements into tangible benefits for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Ujash Sheth, MD MSc FRCSC
Principal Investigator
Sunnybrook Health Sciences Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials